Thryvv : ratio page

Vivo Bio Tech

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
25.29
10.86
25.69
11.31
5.63
PCE(x)
5.41
2.41
5.86
5.70
2.60
Price/Book(x)
1.18
0.56
1.23
1.57
0.76
Yield(%)
0.00
0.00
0.00
0.00
0.00
EV/Net Sales(x)
2.98
1.72
2.38
1.82
0.87
EV/Core EBITDA(x)
6.36
4.10
7.55
5.26
3.86
EV/EBIT(x)
11.29
7.12
13.99
7.65
6.57
EV/CE(x)
1.07
0.79
1.00
1.18
0.78
MCap / Sales
1.41
0.55
1.10
1.24
0.45
Growth Ratio:
Net Sales Growth(%)
-12.98
1.63
-0.74
-6.46
-0.86
Core EBITDA Growth(%)
-2.62
35.11
-9.49
42.82
31.50
EBIT Growth(%)
-4.74
44.20
-28.89
67.23
64.63
PAT Growth(%)
-4.64
20.33
-61.26
27.94
97.58
EPS Growth(%)
-4.64
15.16
-63.55
22.86
89.35
Financial Stability Ratios:
Total Debt/Equity(x)
1.35
1.21
1.47
0.75
0.74
Current Ratio(x)
1.25
1.27
1.12
1.24
1.31
Quick Ratio(x)
1.01
0.95
0.70
0.63
0.79
Interest Cover(x)
1.51
1.58
2.05
3.35
2.37
Total Debt/Mcap(x)
1.14
2.17
1.19
0.48
0.97
Operational & Financial Ratios:
Earnings Per Share (Rs)
1.70
1.78
1.54
4.23
3.45
CEPS(Rs)
7.93
7.99
6.76
8.40
7.46
DPS(Rs)
0.00
0.00
0.00
0.00
0.00
Book NAV/Share(Rs)
36.29
34.49
32.27
30.58
25.56
Tax Rate(%)
37.78
42.67
50.77
34.08
-4.42
Margin Ratios:
Core EBITDA Margin(%)
46.78
41.81
31.31
34.39
22.53
EBIT Margin(%)
26.42
24.14
17.01
23.75
13.28
Pre Tax Margin(%)
8.93
8.85
8.70
16.65
7.68
PAT Margin (%)
5.56
5.07
4.28
10.97
8.02
Cash Profit Margin (%)
26.00
22.81
18.77
21.77
17.37
Performance Ratios:
ROA(%)
1.94
2.16
2.18
8.02
7.58
ROE(%)
4.79
5.44
5.06
15.36
14.85
ROCE(%)
9.97
11.06
9.32
18.81
13.85
Asset Turnover(x)
0.35
0.43
0.51
0.73
0.94
Sales/Fixed Asset(x)
0.32
0.37
0.45
0.68
0.92
Working Capital/Sales(x)
4.88
7.66
18.03
9.86
8.70
Efficiency Ratios:
Fixed Capital/Sales(x)
3.12
2.68
2.20
1.48
1.09
Receivable days
97.07
85.27
68.60
62.65
62.29
Inventory Days
67.24
62.14
81.99
84.09
62.03
Payable days
94.94
87.84
59.11
134.26
165.95